Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV002781768 | SCV003570028 | uncertain significance | Inborn genetic diseases | 2021-08-30 | criteria provided, single submitter | clinical testing | The c.3164A>C (p.Q1055P) alteration is located in exon 24 (coding exon 24) of the RELN gene. This alteration results from a A to C substitution at nucleotide position 3164, causing the glutamine (Q) at amino acid position 1055 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |